Abstract:Objective: Impulse control behaviors (ICBs) frequently coexist with Parkinson's disease (PD). However, the predictors of ICBs in PD remain unclear, and there is limited data on the biological correlates of ICBs in PD. In this study, we examined clinical, imaging, and biological variables to identify factors associated with longitudinal changes in ICBs in early-stage PD. Methods: The data for this study were obtained from the Parkinson's Progression Markers Initiative, an international prospective cohort study that evaluates markers of disease progression in PD. We examined clinical, imaging, and biological variables to determine their associations with ICBs over a period of up to 5 years. Cox regression models were employed to investigate the predictors of ICBs in early-stage, untreated PD. Results: The study enrolled 401 individuals with PD and 185 healthy controls (HC). At baseline, 83 PD subjects (20.7%) and 36 HC (19.5%) exhibited ICBs. Over the course of 5 years, the prevalence of ICBs increased in PD (from 20.7% to 27.3%, p < 0.001), while it decreased in HC (from 19.5% to 15.2%, p < 0.001). Longitudinally, the presence of ICBs in PD was associated with depression, anxiety, autonomic dysfunction, and excessive daytime sleepiness (EDS). However, there was no significant association observed with cognitive dysfunction or motor severity. Treatment with dopamine agonists was linked to ICBs at years 3 and 4. Conversely, there was no association found between ICBs and presynaptic dopaminergic dysfunction. Additionally, biofluid markers in baseline and the first year did not show a significant association with ICBs. A predictive index for ICBs was generated, incorporating three baseline characteristics: anxiety, rapid eye movement sleep behavior disorder (RBD), and p-tau levels in cerebrospinal fluid (CSF). Conclusion: During the early stages of PD, there is a notable increase in ICBs over time. These ICBs are associated with depression, anxiety, autonomic dysfunction, EDS, and the use of dopaminergic medications, particularly dopamine agonists. Anxiety, RBD, and p-tau levels in CSF are identified as predictors for the incident development of ICBs in early PD. Further longitudinal analyses will provide a more comprehensive understanding of the associations between ICBs and imaging findings, as well as biomarkers. These analyses will help to better characterize the relationships and implications of these factors in the context of ICBs in early PD.

Brain structural and functional signatures of impulsive–compulsive behaviours in Parkinson’s disease

Advances in magnetic resonance imaging of impulsive-compulsive behavior in Parkinson′s disease

Risk Factors of Impulsive-Compulsive Behaviors in PD Patients: a Meta-Analysis

Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease

Morphometric alterations of the mesocorticolimbic network in Parkinson's disease with impulse control disorders

Imaging of impulse control disorders in Parkinson's disease

Assessing impulse control behaviors in early Parkinson's disease: a longitudinal study

Aberrant brain topological organization and granger causality connectivity in Parkinson's disease with impulse control disorders

Assessing Impulse Control Behaviors in Early Parkinson’s Disease: a Longitudinal Study

Abnormal Topological Network in Parkinson’s Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging Study

Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders

Multiple Modes of Impulsivity in Parkinson's Disease.

Different impulse control disorder evolution patterns and white matter microstructural damage in the progression of Parkinson's disease

Fixel-based Analysis Reveals Fiber-Specific Alterations During the Progression of Parkinson's Disease.

Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case-control study

Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry.

Impulsivity traits in Parkinson's disease: a systematic review and meta‐analysis

Brain networks and cognitive impairment in Parkinson’s disease

Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours

Changes of brain structure and structural covariance networks in Parkinson's disease associated cognitive impairment

Reorganization of structural brain networks in Parkinson’s disease with postural instability/gait difficulty